SCHEMBL4701641

SCHEMBL4701641

O=C(O)c1cccc(Cc2ccc(O)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.60
CA2 P00918 2/20 0.60
CA9 Q16790 2/20 0.60
FOLH1 Q04609 1/20 0.58
CA12 O43570 1/20 0.55
CA6 P23280 1/20 0.55
PLA2G2A P14555 1/20 0.54
HNF4A P41235 1/20 0.53
TTR P02766 1/20 0.51
ESR1 P03372 1/20 0.50
ESR2 Q92731 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
NR4A2 P43354 1/20 0.50
MRGPRX4 Q96LA9 3/20 0.49
TP53 P04637 1/20 0.49
PKM P14618 1/20 0.49
NFKB1 P19838 1/20 0.49
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1296450 0.89 CA1 (0.63) CA1CA2CA9FOLH1PLA2G2A
SCHEMBL1926951 0.89 FOLH1 (0.66) CA1CA2CA9FOLH1PLA2G2A
SCHEMBL30791058 0.89 FOLH1 (0.70) CA1CA2CA9FOLH1CA12
SCHEMBL70351 0.89 FOLH1 (0.70) CA1CA2CA9FOLH1CA12
Hydrochloric Acid SCHEMBL7136020 0.87 CA1 (0.61) CA1CA2CA9FOLH1PLA2G2A
SCHEMBL29179286 0.85 MRGPRX4 (0.52) CA1CA2CA9FOLH1CA12
SCHEMBL30739488 0.85 MRGPRX4 (0.52) CA1CA2CA9FOLH1CA12
SCHEMBL24484775 0.84 SRD5A2 (0.62) CA1CA2CA9FOLH1PLA2G2A
SCHEMBL6865180 0.84 CA1 (0.62) CA1CA2CA9FOLH1PLA2G2A
SCHEMBL7945362 0.83 ESR1 (0.56) CA1CA2CA9CA12CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114835812-A anti-PD-L1 antibodies and their use for enhancing T cell function 霍夫曼-拉罗奇有限公司 2022-08-02 CN disclosed
CN-105246474-B Life-prolonging composition containing (+) eugenol 株式会社爱茉莉太平洋 2018-06-08 CN disclosed
CN-105246474-A Life-prolonging composition containing (+) eugenol AMOREPACIFIC CORP 2016-01-13 CN disclosed
CN-102612381-B Hazardous agent injection system ANTARES PHARMA INC. (US) 2015-09-09 CN disclosed
CN-104479018-A Anti-pd-l1 antibodies and their use to enhance t-cell function HOFFMANN LA ROCHE 2015-04-01 CN disclosed
CN-102245640-B Anti-PD-L1 antibodies and their use for enhancing T cell function HOFFMANN LA ROCHE 2014-12-31 CN disclosed
CN-102245640-A Anti-PD-L1 antibodies and their use for enhancing T cell function HOFFMANN LA ROCHE 2011-11-16 CN disclosed
EP-1919914-A2 P38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2008-05-14 EP disclosed
WO-2007023115-A2 P38 MAP KINASE INHIBITORS AND METHODS FOR USING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2007-03-01 WO disclosed
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed